1. Kloosterboer SM, Schuiling-Veninga CCM, Bos JHJ, Kalverdijk LJ, Koch BCP, Dieleman GC, et al. Antipsychotics in Dutch youth: prevalence, dosages, and duration of use from 2005 to 2015. J Child Adolesc Psychopharmacol. 2018. https://doi.org/10.1089/cap.2017.0155.
2. Schroder C, Dorks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, et al. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011. Eur Child Adolesc Psychiatry. 2017;26(4):413–20.
3. Deboosere E, Steyaert J, Danckaerts M. Trends in antipsychotics use by Belgian children and adolescents between 2005 and 2014 [in Dutch]. Tijdschr Psychiatr. 2017;59(6):329–38.
4. Eumedica NV. Summary of Product Characteristics in the Netherlands. 2018. Accessible via the Medicines Information Bank of the CBG medicines information board of the Netherlands. Version 031. https://www.geneesmiddeleninformatiebank.nl/smpc/h00183_smpc.pdf. Accessed 10 Apr 2019.
5. Moleman P. Praktische psychofarmacologie. 5th ed. Houten: Prelum; 2009.